PLD1 and glioblastoma: In particular, it has been demonstrated a positive correlation between PLD1 expression and the level of the transmembrane protein cluster of differentiation 44 (CD44), which is a well-recognized marker of the mesenchymal subtype of glioblastoma and a surface marker of cancer stem-like cells and consequently a sign of worse prognosis and a predictor of radio-resistance [50].